Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charalabos Pothoulakis

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Peptides|July 29, 2006
Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammationDezheng Zhao, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 17, 2008
Neuropeptides, mesenteric fat, and intestinal inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Gastroenterology|October 2, 2007
Obesity, innate immunity and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Endocrinology, Diabetes, and Obesity|December 24, 2008
Substance P, obesity, and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Therapeutic Advances in Gastroenterology|March 17, 2012
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTheodoros Kelesidis, Charalabos Pothoulakis
Expert Opinion on Therapeutic Targets|September 23, 2003
Rho GTPases as therapeutic targets for the treatment of inflammatory diseasesDezheng Zhao, Charalabos Pothoulakis
Current Opinion in Gastroenterology|February 9, 2005
Bacterial infections: small intestine and colonStavros Sougioultzis, Charalabos Pothoulakis
Expert Review of Gastroenterology & Hepatology|December 9, 2015
Novel approaches to treating Clostridium difficile-associated colitisDavid Padua, Charalabos Pothoulakis
Inflammatory Bowel Diseases|March 9, 2007
Role of neuropeptides in inflammatory bowel diseaseKara J Gross, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 29, 2006
Immunomodulatory properties of substance P: the gastrointestinal system as a modelHon Wai Koon, Charalabos Pothoulakis
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Peptides|July 29, 2006
Effects of NT on gastrointestinal motility and secretion, and role in intestinal inflammationDezheng Zhao, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 17, 2008
Neuropeptides, mesenteric fat, and intestinal inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Gastroenterology|October 2, 2007
Obesity, innate immunity and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Current Opinion in Endocrinology, Diabetes, and Obesity|December 24, 2008
Substance P, obesity, and gut inflammationIordanes Karagiannides, Charalabos Pothoulakis
Therapeutic Advances in Gastroenterology|March 17, 2012
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disordersTheodoros Kelesidis, Charalabos Pothoulakis
Expert Opinion on Therapeutic Targets|September 23, 2003
Rho GTPases as therapeutic targets for the treatment of inflammatory diseasesDezheng Zhao, Charalabos Pothoulakis
Current Opinion in Gastroenterology|February 9, 2005
Bacterial infections: small intestine and colonStavros Sougioultzis, Charalabos Pothoulakis
Expert Review of Gastroenterology & Hepatology|December 9, 2015
Novel approaches to treating Clostridium difficile-associated colitisDavid Padua, Charalabos Pothoulakis
Inflammatory Bowel Diseases|March 9, 2007
Role of neuropeptides in inflammatory bowel diseaseKara J Gross, Charalabos Pothoulakis
Annals of the New York Academy of Sciences|December 29, 2006
Immunomodulatory properties of substance P: the gastrointestinal system as a modelHon Wai Koon, Charalabos Pothoulakis
Pageof 17